- Home
- ZYXI vs DTF Comparison
ZYXI vs DTF Comparison
Compare ZYXI & DTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- DTF
- Stock Information
- Founded
- ZYXI 1996
- DTF 1991
- Country
- ZYXI United States
- DTF United States
- Employees
- ZYXI N/A
- DTF N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- DTF Investment Managers
- Sector
- ZYXI Health Care
- DTF Finance
- Exchange
- ZYXI Nasdaq
- DTF Nasdaq
- Market Cap
- ZYXI 72.3M
- DTF 78.7M
- IPO Year
- ZYXI N/A
- DTF N/A
- Fundamental
- Price
- ZYXI $2.39
- DTF $11.26
- Analyst Decision
- ZYXI Buy
- DTF
- Analyst Count
- ZYXI 3
- DTF 0
- Target Price
- ZYXI $6.00
- DTF N/A
- AVG Volume (30 Days)
- ZYXI 257.6K
- DTF 21.1K
- Earning Date
- ZYXI 07-24-2025
- DTF 01-01-0001
- Dividend Yield
- ZYXI N/A
- DTF 3.64%
- EPS Growth
- ZYXI N/A
- DTF N/A
- EPS
- ZYXI N/A
- DTF 0.44
- Revenue
- ZYXI $172,401,000.00
- DTF N/A
- Revenue This Year
- ZYXI N/A
- DTF N/A
- Revenue Next Year
- ZYXI $19.55
- DTF N/A
- P/E Ratio
- ZYXI N/A
- DTF $24.34
- Revenue Growth
- ZYXI N/A
- DTF N/A
- 52 Week Low
- ZYXI $1.66
- DTF $10.29
- 52 Week High
- ZYXI $10.62
- DTF $11.19
- Technical
- Relative Strength Index (RSI)
- ZYXI 48.86
- DTF 54.89
- Support Level
- ZYXI $2.31
- DTF $11.18
- Resistance Level
- ZYXI $2.72
- DTF $11.24
- Average True Range (ATR)
- ZYXI 0.18
- DTF 0.04
- MACD
- ZYXI -0.01
- DTF 0.00
- Stochastic Oscillator
- ZYXI 17.31
- DTF 78.57
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About DTF DTF Tax-Free Income 2028 Term Fund Inc.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing primarily in a diversified portfolio of investment-grade tax-exempt obligations.